Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 244 | 251 | 3,960 | 3,564 | 164 |
| Gross Profit | 244 | 251 | 3,960 | 3,564 | 164 |
| Operating Expenses | 7,291 | 7,891 | 9,991 | 5,997 | 6,578 |
| Operating Income | -7,047 | -7,640 | -6,031 | -2,433 | -6,415 |
| Other Income | 409 | 433 | 325 | 317 | 320 |
| Pre-tax Income | -6,638 | -7,207 | -5,706 | -2,116 | -6,095 |
| Net Income Continuous | -6,638 | -7,207 | -5,709 | -2,116 | -6,095 |
| Net Income | $-6,638 | $-7,207 | $-5,709 | $-2,116 | $-6,095 |
| EPS Basic Total Ops | -0.28 | -0.32 | -0.34 | -0.13 | -0.36 |
| EPS Basic Continuous Ops | -0.28 | -0.32 | -0.34 | -0.13 | -0.36 |
| EPS Diluted Total Ops | -0.28 | -0.32 | -0.34 | -0.13 | -0.36 |
| EPS Diluted Continuous Ops | -0.28 | -0.32 | -0.34 | -0.13 | -0.36 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.32 | -0.34 | -0.10 | -0.36 |
| EBITDA(a) | $-7,044 | $-7,637 | $-6,024 | $-2,426 | $-6,408 |